New Normal Labs ApS: Financial statements 2022
CVR: 39733560
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
New Normal Labs ApS (CVR 39733560) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 32,642 and a net result of DKK 32,299 compared with DKK -19,527 the year before. Equity in the 2022 report amounted to DKK 36,325. The solvency ratio was 56%.
- Gross Profit
- DKK 32,642
- Profit/Loss
- DKK 32,299
- Equity
- DKK 36,325
- Total Assets
- DKK 64,889
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 33 t. | 32 t. | 36 t. | - |
| 2021 | - | -19 t. | -20 t. | 4 t. | - |
| 2020 | - | - | 6 t. | -17 t. | - |
Official annual report
Keep an eye on New Normal Labs ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
New Normal Labs ApS has published its annual report for 2021. Gross profit came to DKK -19,412, and the net result was DKK -19,527.
About New Normal Labs ApS
New Normal Labs ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Undervisning inden for sport og fritid. The management consists of Martin Kremmer. In 2025, the company reported a gross profit of DKK -1,868 and a net result of DKK -3,283 compared with DKK -7,022 the year before. Equity in the 2025 report amounted to DKK 8,391.